Annual Report

Overview

The report describes SPARC's R&D-led model across oncology, neurodegeneration and immunology, with seven clinical trials involving three NCEs underway. It reports 410 employees as of March 31, 2021 and total turnover of ₹25,836.96 lakhs. The company did not spend on CSR because average net profit for the preceding three years was negative, while its BRR reports no climate-change strategy or renewable-energy initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020-2021
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services